Hyperliquid Strategies Inc (PURR) Q1 2027 earnings review
Hyperliquid Strategies buys more tokens, but share dilution stalls per-share gains
Hyperliquid Strategies — a treasury company that buys and stakes HYPE, the token of the Hyperliquid trading blockchain — expanded its token pile while applying for a US derivatives broker licence. The company raised $911 million by selling stock and spent $785 million to buy 9.1 million HYPE tokens, lifting its holdings by nearly one-third and doubling staking revenue. Chief executive David Schamis paired that buying with an application to become a futures commission merchant so the firm can carry US client accounts for regulated markets on Hyperliquid.
| Staking and validator revenue | $12.3M +95% from last quarter |
|---|---|
| HYPE tokens held | 38.5M +32% from June 30 (worth $3.51B) |
| Net income | $620.6M includes $803M unrealized token gain |
| Operating expenses | $7.6M vs ~$4M quarterly baseline (+81%) |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because new catalysts on the blockchain balanced out stalled per-share token growth at the company. On the positive side, the broker filing creates a path to US operating revenue, and by our math quarterly fees accruing to the Hyperliquid ecosystem rose 15% to $209 million after falling for three quarters. The bad news: the company paid $86 per token using newly issued shares, so by our math HYPE tokens per diluted share barely moved, while operating expenses nearly doubled to $7.6 million.
The question now is whether the share-issuance model can still grow tokens per share at higher HYPE prices and whether US regulators will approve the broker plan. Supporters point to share sales above book value and rising blockchain fees from stablecoin interest, while sceptics point to heavy share dilution, insider warrant rights and a $7.6 million cost bill. The quarterly filing's share-count and related-party footnotes will settle the dilution math.
🐂 Bull Case
Filing for a US Broker Licence Opens an Onshore Path
Hyperliquid Strategies holds HYPE, the digital token of the Hyperliquid trading blockchain, and wants US traders to use that network legally. A subsidiary applied this quarter to become a futures commission merchant (FCM), a registered broker that holds client money for derivatives trading. Chief executive David Schamis said "setting up an FCM is how we intend to help bring markets deployed on Hyperliquid onshore."
The filing pairs with a planned blockchain upgrade called HIP-3, which lets outside operators "build and launch permissioned markets on Hyperliquid's onchain infrastructure". Those operators would check customer identities, while the company's broker unit would carry US client accounts for "bringing perpetual futures to US customers within a regulated framework".
This matters because turning the company from a passive token holder into a licensed US broker could open the blockchain to American institutions and generate brokerage fees. The company cautioned that it cannot guarantee the timing or approval of the licence.
What to watch: feedback from US derivatives regulators on the broker application over the coming quarters. Approval would let the firm sign up US trading clients and earn operating income beyond token staking.
Staking Revenue Nearly Doubled as Validator Reached Top Rank
The company earns recurring revenue by staking its HYPE tokens — locking them up to help verify transactions on the blockchain — and running a validator node with partner Unit Labs. In the quarter ended September 30, staking and validator revenue reached $12.3 million, up 95% from $6.3 million last quarter. Its joint validator is now the "largest non-Foundation validator on the network", up from third place in the prior period.
Revenue climbed because the treasury held 38.5 million tokens at quarter-end, up 32% from June, and the token price rose 40% to $90.99. By our math, the annualized yield on average token value was about 1.8%, down slightly from 2.1% last quarter because network reward rates fall as more users stake tokens.
What to watch: the separate dollar figure for validator commissions in the full quarterly filing. A growing commission number would show the validator earns outside fees rather than just pass-through rewards on the firm's own tokens.
Protocol Fee Generation Turned Upward After Three Falling Quarters
Nearly all fees generated on the Hyperliquid blockchain go toward automatic daily buybacks of the HYPE token. That fee pool had shrunk for three straight quarters, falling from $324 million in the September 2025 quarter to $182 million in the June 2026 quarter as low-fee commodity and index trading replaced higher-fee crypto trading.
The company reported that about $834 million in value accrued to the Hyperliquid ecosystem over the twelve months ended September 30. Subtracting the prior three quarters from that twelve-month total leaves about $209 million for the September quarter by our math, a 15% rise from the June quarter. That rebound matches the late-August start of an agreement with Coinbase and Circle that routes 90% of reserve interest on platform USDC stablecoins to the protocol.
What to watch: the quarterly ecosystem value table in the presentation or filing for the December quarter. A first full quarter of USDC reserve interest should push quarterly protocol value higher if trading volumes hold steady.
🐻 Bear Case
Buying High-Priced Tokens With New Shares Left Per-Share Holdings Unchanged
Hyperliquid Strategies aims to accumulate HYPE tokens in a way that increases the tokens held behind each share, while tying all of its assets to a single volatile token. Management also sells new stock when shares trade above net asset value and buys back stock when they dip below it. "We deployed $802 million this quarter and filed an application to become a futures commission merchant," Schamis said.
- Equity raised in Q1: $911 million under the committed equity facility, bringing total proceeds since December 2025 to $1,578.4 million at $10.36 per share
- New shares issued since June 30: about 76.3 million shares at an average price of $12.21 by our math, matching the 76.1 million issued across all of last fiscal year
- Token purchases in Q1: $785 million for 9.1 million HYPE tokens, or $86.26 per token by our math, pushing the blended cost up from $46.57 to $56.35
- Share buybacks in Q1: $17 million to repurchase 2.7 million shares at $6.30 each by our math
Because the company paid $86.26 per token while expanding its diluted share count before warrants by roughly one-third to about 301 million shares by our math, HYPE tokens per diluted share barely budged at 0.1292 against 0.1287 in June. Issuing shares added scale, not per-share tokens.
What to watch: the exact basic and diluted share counts in the quarterly filing. Those figures will confirm whether per-share token growth has stalled after accounting for 28.7 million outstanding warrants.
Operating Expenses Nearly Doubled and Token Swings Still Drive Profit
Last quarter, finance chief Brett Beldner said $4 million per quarter was a reasonable expectation for ongoing selling, general, administrative and research costs after exiting the legacy biotech business. In the September quarter, those operating expenses climbed 81% from last quarter to $7.6 million, nearly double Beldner's baseline, as the company prepared its US broker application.
Because staking revenue grew even faster, operating expenses fell by 2.0 percentage points of revenue to 57.1%, leaving $5.7 million in operating profit before token marks by our math. Even so, paper token gains and non-cash charges still swamp daily operations: reported net income of $620.6 million came from $803.0 million in unrealized HYPE gains, minus $172.3 million in income tax provisions and $15.3 million in equity facility costs.
What to watch: the expense breakdown in the quarterly filing. It will show how much of the $3.4 million cost increase came from one-time legal and regulatory filings versus permanent payroll.
Risks this quarter didn't answer
The earnings release omitted share count tables and footnote disclosures needed to track three standing governance and balance-sheet risks.
- Advisor dilution rights and lock-up: an affiliate advisor holds a revocable waiver on rights to receive 5% in shares and 15% in warrants on every equity raise, plus shares whose lock-up expires by December 2, 2026; the quarterly filing's related-party note will show if the waiver still holds.
- Warrant dilution: 28.7 million warrants sat near or in the money last quarter, and the filing's equity footnote will show how many entered the diluted share count as the stock rose.
- Custody concentration: substantially all HYPE tokens sit with a single custodian, Anchorage Digital, and the filing will show whether the $3.5 billion treasury remains in one place.
💲 Other KPIs
Cash reserves rose 69.8% from $149.9 million at June 30, because the company raised $911 million under its equity facility and deployed $802 million into tokens and share buybacks. By October 28, cash stood at $245.3 million with zero debt, giving management a large buffer to buy back stock if shares trade below net asset value.
Stockholders' equity — the book value of the treasury after liabilities — climbed 81.7% from $1,872.9 million in June, following a 151.9% rise the quarter before. The $1.53 billion increase came from $911 million in new share sales and $620.6 million in net income from higher HYPE token prices, with zero debt on the balance sheet.
By our math, total liabilities — the difference between $3,764.3 million in total assets and $3,403.0 million in stockholders' equity — rose 93.1% from $187.1 million at June 30. The increase follows a $172.3 million income tax provision booked on unrealized HYPE token gains, which turns into a cash tax bill only if the company sells tokens.
❓ Key Questions
Did HYPE tokens per diluted share grow this quarter?
The company raised $911 million by selling shares and bought 9.1 million HYPE tokens at about $86.26 each. Because the release omits share and warrant counts, investors cannot verify if the share sales added tokens on a per-share basis.
Why did operating expenses jump to $7.6 million?
Selling, general, administrative and research costs rose 81% from $4.2 million last quarter, well above management's $4 million steady-state estimate. Investors need to know how much of that spend went toward the new broker application versus ongoing overhead.
Will the strategic advisor extend its equity-grant waiver?
An affiliate advisor has waived its right to take 5% in shares and 15% in warrants on every equity raise, but can revoke that waiver on two weeks' notice. In addition, the lock-up on the advisor's initial shares expires on December 2, 2026.
How much revenue came from outside validator commissions?
Staking and validator revenue reached $12.3 million as the firm's node became the largest non-Foundation validator on Hyperliquid. Breaking out third-party commissions from rewards on the company's own tokens would show whether the node business earns significant outside income.